ST
Summit Therapeutics PLC
🇺🇸XNAS.SMMTUnited StatesHealthcare
$17.39USDdown -0.02 (-0.11%)ClosedDelayed12:25 PM
Price$17.39-0.02 (-0.11%)
Profile
- Healthcare
- Biotechnology
- United States
Identity
- Exchange
- Nasdaq . XNAS
- Type
- Stock
- ISIN
- US86627T1088
- CUSIP
- 86627R102
Company
- Employees
- 265
- Headquarters
- Miami, United States
- Website
- https://www.smmttx.com
- CEO
- Dr. Mahkam Zanganeh D.D.S., M.B.A.
Market
- Shares outstanding
- 797.7M
- Market cap
- $13.87B
Key dates
- Next earnings
- Oct 19, 2026
Highlights
- Market cap
- $13.87B
- EPS LTM
- -£1.07calculatedCalculated by Finzer, not reported by the data provider.
- P/E LTM
- Not reported
- Div yield
- Not reported
Fundamentals (LTM)
- Revenue
- £00%unchanged year on year
- Net income
- -£856.09M-130.47%down year on year
- Gross margin
- Not reported
- Free cash flow
- -£430.6M-140.54%down year on year
Other listings
This company is not listed on any other exchange we cover.
These are the venues Finzer covers, not every venue that exists.
Business summary
No company summary reported yet.